Long-term expansion of the regenerative medicine market
First written in FY2021-Q1. 7 of 10 entries say "Restated". Latest entry: FY2025-H1.
1 other company's latest entry also says "Other".
- FY2025-H1Market forecast updatedAnnual report
「The global regenerative medicine market has now reached US$26.7 billion in 2024 and is forecast to grow to US$130.4 billion by 2033, suggesting that demand for regenerative medicine is expected to continue rising steadily.」
A new global market-size forecast, from US$26.7 billion in 2024 to US$130.4 billion in 2033, was presented in place of the previously stated forecasts, including growth from US$16 billion in 2023 to US$49 billion in 2028. - FY2024Market forecast updatedAnnual report
「The global regenerative medicine market is also forecast to grow from US$16 billion in 2023 to US$49 billion in 2028, demonstrating the significant expectations for new medical treatments for diseases that have been difficult to treat with conventional pharmaceuticals and medicine.」
In addition to the previous market-size forecast for 2020 to 2050, a new global market forecast from US$16 billion in 2023 to US$49 billion in 2028 was presented. - FY2024-Q3RestatedAnnual report
「Market forecasts for regenerative medicine indicate substantial growth, from ¥95 billion in Japan in 2020 to ¥2.5 trillion in 2050, and from ¥1 trillion globally in 2020 to ¥38 trillion in 2050. These figures demonstrate the significant expectations for new medical treatments for diseases that have been difficult to treat with conventional pharmaceuticals and medicine.」
The forecast for expansion of the regenerative medicine market in Japan and globally through 2050 has been reaffirmed. - FY2024-Q1RestatedAnnual report
「Market forecasts for regenerative medicine indicate substantial growth, from ¥95 billion in Japan in 2020 to ¥2.5 trillion in 2050, and from ¥1 trillion globally in 2020 to ¥38 trillion in 2050. These figures demonstrate the significant expectations for new medical treatments for diseases that have been difficult to treat with conventional pharmaceuticals and medicine.」
The forecast for expansion of the regenerative medicine market in Japan and globally through 2050 has been reaffirmed. - FY2023-Q1RestatedAnnual report
「Market forecasts for regenerative medicine indicate substantial growth, from ¥95 billion in Japan in 2020 to ¥2.5 trillion in 2050, and from ¥1 trillion globally in 2020 to ¥38 trillion in 2050. These figures demonstrate the significant expectations for new medical treatments for diseases that have been difficult to treat with conventional pharmaceuticals and medicine.」
The forecast for expansion of the regenerative medicine market in Japan and globally through 2050 has been reaffirmed. - FY2022RestatedAnnual report
「Market forecasts for regenerative medicine indicate substantial growth, from ¥95 billion in Japan in 2020 to ¥2.5 trillion in 2050, and from ¥1 trillion globally in 2020 to ¥38 trillion in 2050. These figures demonstrate the significant expectations for new medical treatments for diseases that have been difficult to treat with conventional pharmaceuticals and medicine.」
The forecast for substantial expansion of the regenerative medicine market in Japan and globally through 2050 has been reaffirmed. - FY2022-Q1RestatedAnnual report
「Market forecasts for regenerative medicine indicate substantial growth, from ¥95 billion in Japan in 2020 to ¥2.5 trillion in 2050, and from ¥1 trillion globally in 2020 to ¥38 trillion in 2050. These figures demonstrate the significant expectations for new medical treatments for diseases that have been difficult to treat with conventional pharmaceuticals and medicine.」
The forecast for expansion of the regenerative medicine market in Japan and globally through 2050 has been reaffirmed. - FY2021-Q3RestatedAnnual report
「Market forecasts for regenerative medicine indicate substantial growth, from ¥95 billion in Japan in 2020 to ¥2.5 trillion in 2050, and from ¥1 trillion globally in 2020 to ¥38 trillion in 2050. These figures demonstrate the significant expectations for new medical treatments for diseases that have been difficult to treat with conventional pharmaceuticals and medicine.」
The forecasts for expansion of the regenerative medicine market in Japan and globally from 2020 to 2050 have been reproduced. - FY2021-Q2RestatedAnnual report
「Market forecasts for regenerative medicine indicate substantial growth, from ¥95 billion in Japan in 2020 to ¥2.5 trillion in 2050, and from ¥1 trillion globally in 2020 to ¥38 trillion in 2050. These figures demonstrate the significant expectations for new medical treatments for diseases that have been difficult to treat with conventional pharmaceuticals and medicine.」
The forecasts for expansion of the regenerative medicine market in Japan and globally from 2020 to 2050 have been reproduced. - FY2021-Q1First statedAnnual report
「Market forecasts for regenerative medicine indicate substantial growth, from ¥95 billion in Japan in 2020 to ¥2.5 trillion in 2050, and from ¥1 trillion globally in 2020 to ¥38 trillion in 2050. These figures demonstrate the significant expectations for new medical treatments for diseases that have been difficult to treat with conventional pharmaceuticals and medicine.」
For the regenerative medicine market, market-size forecasts from 2020 to 2050 for Japan and the global market are presented for the first time.